AbCellera (ABCL) reported Q2 EPS of ($0.02), $0.02 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $46 million versus the consensus estimate of $53.59 million.
AbCellera (ABCL) reported Q2 EPS of ($0.02), $0.02 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $46 million versus the consensus estimate of $53.59 million.